Through the partnership, ACC will review Aidoc’s technology so it can better identify patients with CAC, a precursor to several cardiovascular diseases, even when they aren’t visiting a cardiologist, according to a Feb. 29 press release.
Aidoc’s FDA-cleared technology can communicate findings to radiologists to coordinate automatic patient follow-up care.
Even if a patient’s initial bodily scan is unrelated to cardiovascular concerns, Aidoc’s AI applies algorithms based on visible anatomy and reports any existing CAC risks to a radiology team.
The ACC and Aidoc partnership will focus on three things: refining solutions, integrating ACC guidelines and promoting health equity.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
